NVST insider trading
HealthcareEnvista Holdings Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Envista Holdings Corp
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products, as well as provides DTX Studio Clinic, a software package offered with its imaging products. This segment offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.
Company website: envistaco.com
NVST insider activity at a glance
FilingIQ has scored 397 insider transactions for NVST since Sep 20, 2019. The most recent filing in our index is dated Feb 25, 2026.
Across the full history, 17 open-market purchases
and 85 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on NVST insider trades is 61.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest NVST Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for NVST?
- FilingIQ tracks 397 Form 4 insider transactions for NVST (Envista Holdings Corp), covering filings from Sep 20, 2019 onwards. 30 of those were filed in the last 90 days.
- Are NVST insiders net buyers or net sellers?
- Across the full Form 4 history for NVST, 17 transactions (4%) were open-market purchases and 85 (21%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NVST insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is NVST in?
- Envista Holdings Corp (NVST) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $4.67B.
Methodology & sources
Every NVST insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.